Ruxolitinib as salvage therapy for neonatal HLH in preterm twins born to a mother with adult-onset Still’s disease
Paediatrics
Ruxolitinib as salvage therapy for neonatal HLH in preterm twins born to a mother with adult-onset Still’s disease
Paediatrics

Ruxolitinib as salvage therapy for neonatal HLH in preterm twins born to a mother with adult-onset Still’s disease

Pediatr Int. 2025 Jan-Dec;67(1):e70203. doi: 10.1111/ped.70203.

NO ABSTRACT

PMID:40955523 | DOI:10.1111/ped.70203